Skip to main content
OpenTrials
Completed

NCT Number: NCT07099105

Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer

The goal of this observational study is compared the perioperative outcomes of robotic lobectomy using the SP system via the subcostal approach with those of multi-port robotic lobectomy using the Xi system via the intercostal approach.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Korea University Guro Hospital

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients aged > 18 years who underwent RATS lobectomy for NSCLC at the Korea University Guro Hospital between January 2017 and December 2024

Exclusion criteria

  • patients who underwent Viedo-assisted thoracic surgery lobectomy
  • patients who underwent robotic lobectomy with other combined surgery
  • patients who received neoadjuvant therapy

Treatment and study plan

Primary outcomes

  1. Postoperative pain

    Time frame: Postoperatively day 0,1,2,3

    Postoperative pain using visual analog scale (minimum =0, maximum=10), A lower value reflects a lesser degree of pain perception (lower scores mean a better outcome)

Secondary outcomes

  1. chest tube duration

    Time frame: Perioperative

    Chest tube duration refers to the number of days a thoracic drain remains in situ following pulmonary surgery. The duration is measured in days (minimum: 1, maximum: no defined). Lower scores indicate a better outcome.

Sponsors and collaborators

Lead sponsor

Korea University Guro Hospital

Other

Registry information

Official study title

Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer: A Single-centre Retrospective Propensity Matched Study

Acronym: SP vs MP robot

Important dates

Study start
2017
Primary completion
2024
Study completion
2024
First posted
Aug 1, 2025
Registry last updated
Aug 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.